<h1 id="seizures-and-status-epilepticus">Seizures and Status Epilepticus</h1>
<h2 id="generalized-convulsive-status-epilepticus-gcse-">Generalized Convulsive Status Epilepticus (GCSE)</h2>
<ul>
<li>Continuous seizure activity ≥ 10 min, or at least 2 seizures without full recovery of consciousness between seizures <em>(VA Cooperative Trial on Treatment of GCSE)</em></li>
</ul>
<h2 id="mortality">Mortality</h2>
<p>10-40% for adults. If ≥ 60 minutes of ongoing sz activity, loss of compensatory mechanisms.</p>
<h2 id="causes">Causes</h2>
<p>Most common in adults: Cerebrovascular disease</p>
<p>Most common in pediatrics: Fever and infection</p>
<p><strong>Infectious</strong></p>
<ul>
<li>Meningitis</li>
<li>Encephalitis</li>
<li>Brain abscess</li>
</ul>
<p><strong>Vascular</strong> </p>
<ul>
<li>Ischemic CVA</li>
<li>SAH</li>
<li>SDH</li>
<li>EDH</li>
<li>Vasculitis</li>
</ul>
<p><strong>Metabolic</strong></p>
<ul>
<li>Hyponatremia</li>
<li>Hypoglycemia</li>
<li>Hypocalcemia</li>
<li>Hypomagnesemia</li>
</ul>
<p><strong>Toxic</strong></p>
<ul>
<li>Cocaine`</li>
<li>Tricyclics</li>
<li>Anticholinergics</li>
<li>EtOH withdrawal</li>
</ul>
<p><strong>Tumors</strong></p>
<p><strong>Eclampsia</strong></p>
<p><strong>Recent change in medication</strong></p>
<h2 id="workup">WORKUP</h2>
<p><strong>Labs:</strong></p>
<ul>
<li>Serum electrolytes, calcium, magnesium, glucose, BUN, Creatinine, LFT</li>
<li>Antiepileptic drug levels, if appropriate</li>
<li>Urine tox screen</li>
<li>Consider: EtOH, Aspirin/Acetaminophen level, tricyclics tox screen</li>
<li>Consider: LP procedure, if suspect CNS infection</li>
<li>Note: A challenge is that GCSE can actually cause fevers and cause WBC in CSF</li>
</ul>
<p><strong>Imaging:</strong> Noncontrast head CT</p>
<p><strong>EEG:</strong> Not indicated in the ED, however: <a href="http://www.ncbi.nlm.nih.gov/pubmed/9701373">(DeLorenzo RJ et al, Epilepsia 1998)</a></p>
<ul>
<li>Useful to help assess subtle GCSE after persistent comatose state after termination of apparent sz, or when paralytics or heavy sedation medications used (masks sz activity)</li>
<li>48% of patients continued to have subtle sz on EEG monitoring in first 24 hrs despite no signs of ongoing convulsions.</li>
</ul>
<h2 id="management">Management</h2>
<ol>
<li>Secure airway and establish IV access</li>
<li>Bedside glucose check. Treat if glucose &lt; 80 mg/dL or unable to determine.</li>
<li>Benzodiazepine: <strong><span class="drug">Diazepam</span></strong> and <strong><span class="drug">lorazepam</span></strong> equally effective in stopping sz. Because of <span class="drug">lorazepam’s</span> smaller volume of distribution, CNS levels remain more constant over longer period.</li>
<li><p><strong><span class="drug">Phenytoin</span> / <span class="drug">fosphenytoin</span></strong>: Dose 20 mg <strong><span class="drug">Phenytoin</span></strong> max rate of infusion = 50 mg/min, because of hypotension from propylene glycol diluent. Need large bore IV because of caustic ph of 12.</p>
<ul>
<li><strong><span class="drug">Fosphenytoin</span></strong> max rate of infusion = 150 mg/min (more neutral pH 9). Conversion to phenytoin half-life = 8-15 minutes.</li>
</ul>
</li>
<li><p>Consider <strong><span class="drug">pyridoxine</span></strong> (B6) for possible INH toxicity (5 g IV over 3-5 minutes)</p>
</li>
<li><strong><span class="drug">Thiamine</span></strong> 100 mg IV — if malnourished or chronic EtOH abuse history</li>
<li><strong><span class="drug">Ceftriaxone</span></strong> 2 g IV and <strong><span class="drug">vancomycin</span></strong> 1 g IV — if suspect CNS infection</li>
</ol>
<p>If refractory above treatment, consider any of following:</p>
<ul>
<li><strong><span class="drug">Midazolam</span></strong>: 0.2 mg/kg bolus, 0.05-2 mg/kg/hr infusion</li>
<li><strong><span class="drug">Propofol</span>:</strong> 3-5 mg/kg bolus, 1-15 mg/kg/hr infusion. Risk: hypotension, lipidemia, metabolic acidosis</li>
<li><strong><span class="drug">Pentobarbital</span>:</strong> 5-15 mg/kg load over 1 hour, then 0.5-10 mg/kg/hr infusion. Risk of hypotension.</li>
</ul>
<!-- -->
<h2 id="medication-algorithm-summary-for-status-epileptics">Medication Algorithm Summary for Status Epileptics</h2>
<p><img src="https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/5/m/38518f42-051d-5f04-a720-523b41da3b4a/640.png" alt=""></p>
<h2 id="references">References</h2>
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/9701373">DeLorenzo RJ, Waterhouse EJ, Towne AR, Boggs JG, Ko D, DeLorenzo GA, Brown A, Garnett L.Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. 1998 Aug;39(8):833-40.</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Generalized+convulsive+status+epilepticus+in+adults+and+children%3A+treatment+guidelines+and+protocols.">Shearer P, Riviello J.Generalized convulsive status epilepticus in adults and children: treatment guidelines and protocols. EM Clinics of NA. 2011, 29:51-64</a></li>
</ul>
